medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2024, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2024; 22 (3)

Squamous cell carcinoma in scalp with intracranial invasion. Case report

Fajardo LT, Remache OV, Fuenmayor GL

Language: Spanish
References: 11
Page: 236-239
PDF size: 210.20 Kb.


ABSTRACT

Squamous cell carcinoma (SCC) is a malignant tumor of the epidermis that mainly affects older adults. Factors such as the location, diameter, and depth of the lesion, as well as the patient’s immune status and the histological grade of the tumor, are associated with a greater probability of recurrence, the development of metastasis, and with a higher mortality.
We report a 77-year-old woman diagnosed with SCC characterized rapid progression and invasion into the cranial cavity and failure of chemotherapy. Early diagnosis is emphasized to avoid the aggressive progression of SCC.


REFERENCES

  1. Páez AM, Hinojosa S, Jaramillo D y Pareja PY, Carcinoma epidermoidecutáneo invasivo a cráneo. Reporte de un caso, RevistaMed 2014; 22(1):50-7.

  2. Gocmen S, Intracranial extension of squamous cell carcinomaof the scalp: a case report. Disponible en: https://www.researchgate.net/publication/288277653.

  3. Combalia A y Carrera C, Squamous cell carcinoma: an updateon diagnosis and treatment, Dermatol Pract Concept 2020;10(3):e2020066. Consultado el 25 de diciembre de 2023. Disponibleen: https://doi.org/10.5826/dpc.1003a66.

  4. Andrade P, Brites MM, Vieira R, Mariano A, Reis JP, Tellechea Oet al., Epidemiology of basal cell carcinomas and squamous cellcarcinomas in a department of dermatology: a 5 year review,An Bras Dermatol 2012; 87(2):212-9. Consultado el 25 de diciembrede 2023. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22570024/.

  5. Alam M, Armstrong A, Baum C, Bordeaux JS, Brown M, BusamKJ et al., Guidelines of care for the management of cutaneoussquamous cell carcinoma, J Am Acad Dermatol 2018;78(3):560-78. Consultado el 25 de diciembre de 2023. Disponibleen: https://pubmed.ncbi.nlm.nih.gov/29331386/.

  6. Kim C, Cheng J y Colegio OR, Cutaneous squamous cell carcinomasin solid organ transplant recipients: emerging strategiesfor surveillance, staging, and treatment, Semin Oncol 2016;43(3):390-4. Consultado el 25 de diciembre de 2023. Disponibleen: https://pubmed.ncbi.nlm.nih.gov/27178693/.

  7. Brantsch KD, Meisner C, Schönfisch B, Trilling B, Wehner-CaroliJ, Röcken M et al., Analysis of risk factors determining prognosisof cutaneous squamous-cell carcinoma: a prospectivestudy, Lancet Oncol 2008; 9(8):713-20. Consultado el 25 de diciembrede 2023. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18617440/.

  8. Que SKT, Zwald FO y Schmults CD, Cutaneous squamous cellcarcinoma: incidence, risk factors, diagnosis, and staging, Journalof the American Academy of Dermatology, vol. 78, Mosby,2018, pp. 237-47.

  9. Etlik Ö, Bay A, Izmirli M, Ugˇras¸ S, Yilmaz N y Turan A, Deep intracranialextension of squamous cell carcinoma of the scalp,Pediatr Blood Cancer 2005; 45(7):994-6.

  10. Etlik Ö, Bay A, Izmirli M, Ugˇras¸ S, Yilmaz N y Turan A, Deep intracranialextension of squamous cell carcinoma of the scalp,Pediatr Blood Cancer 2005; 45(7):994-6.

  11. Ahmadi N y Newkirk K, Intracranial extension of cutaneoussquamous cell carcinoma, Otolaryngology–Head and Neck Surgery2010; 143(S2).




2020     |     www.medigraphic.com